News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gheuens Sarah
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/06/2023 |
4
| Gheuens Sarah (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 25,124 restricted stock units
@ $0 |
|
| 06/30/2023 |
4
| Gheuens Sarah (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 1,707 shares
@ $28.36, valued at
$48.4k
Exercised 5,750 options to buy
@ $0 |
|
| 12/28/2022 |
4
| Gheuens Sarah (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,783 shares
@ $28.48, valued at
$79.3k
Exercised 9,375 restricted stock units
@ $0 |
|
| 12/06/2022 |
4
| Gheuens Sarah (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 248 shares
@ $28.83, valued at
$7.1k
Exercised 833 restricted stock units
@ $0 |
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Gheuens Sarah (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 758 shares
@ $31.425, valued at
$23.8k
Exercised 2,162 restricted stock units
@ $0 |
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|